Composition: Ondansetron IP 8 mg
Ondidrop-8 Ondidrop-8 delivers a higher strength 8 mg dose of Ondansetron in a convenient orally disintegrating tablet format, designed for managing more pronounced nausea and vomiting linked to highly emetogenic chemotherapy regimens or major surgical interventions. Its rapid dissolution mechanism ensures immediate systemic absorption and patient compliance, making it an essential clinical tool in oncology and post-operative care.
Find answers regarding product efficacy, clinical specifications, and distribution rights.
Specialty Range
Specialty Range
Specialty Range
Specialty Range
Specialty Range
Specialty Range
Specialty Range
Specialty Range
Specialty Range
Specialty Range
Specialty Range
